Tezepelumab: A Potential New Biological Therapy for Severe Refractory Asthma
Corrado Pelaia(Magna Graecia University), Alessandro Vatrella(University of Salerno), Luca Gallelli(Magna Graecia University), Angelantonio Maglio(University of Salerno), Giulia Pelaia(Magna Graecia University), Rosa Terracciano(Magna Graecia University), Claudia Crimi(Marconi University)
Cited by 74
Related Papers
A European survey of noninvasive ventilation practices
|European Respiratory Journal|2010|205
Determinants of tracheostomy decannulation: an international survey
|Critical Care|2008|177
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study
|Arthritis & Rheumatology|2021|165
Interleukins 4 and 13 in Asthma: Key Pathophysiologic Cytokines and Druggable Molecular Targets
|Frontiers in Pharmacology|2022|157
Molecular Targets for Biological Therapies of Severe Asthma
|Frontiers in Immunology|2020|132